Yang S, Dai D, Kang Z, Zhang L, et al. Immunogenicity and safety of a quadrivalent recombinant human papillomavirus vaccine (type 6/11/16/18) (Hansenula polymorpha): A randomized controlled phase 2 non-inferiority clinical trial. Vaccine 2026;80:128527.
PMID: 41932289